Home/Filings/4/A/0001209191-23-023783
4/A//SEC Filing

Ildstad Suzanne 4/A

Accession 0001209191-23-023783

CIK 0001827506other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:19 PM ET

Size

8.4 KB

Accession

0001209191-23-023783

Insider Transaction Report

Form 4/AAmended
Period: 2023-02-21
Ildstad Suzanne
DirectorChief Scientific Officer10% Owner
Transactions
  • Sale

    Common Stock

    2023-02-21$2.05/sh3,500$7,1853,071,395 total
Holdings
  • Common Stock

    (indirect: See footnote)
    654,205
  • Common Stock

    (indirect: See footnote)
    654,205
  • Common Stock

    (indirect: by GRAT)
    1,200,000
Footnotes (4)
  • [F1]This amendment is being filed solely to indicated the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2022.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]These shares are held in a trust for the benefit of the Reporting Person's son. The Reporting Person's son is co-trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F4]These shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's daughter is co-trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Issuer

Talaris Therapeutics, Inc.

CIK 0001827506

Entity typeother

Related Parties

1
  • filerCIK 0001845822

Filing Metadata

Form type
4/A
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:19 PM ET
Size
8.4 KB